Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, announced today that Chris Xu, PhD, its chief executive officer, will be the keynote speaker on day two of the Cell Therapy World Asia (CTWA) 2018 conference
September 13, 2018
· 2 min read